The global Ceftriaxone Sodium market size was valued at US$ 264 million in 2024 and is forecast to a readjusted size of USD 219 million by 2031 with a CAGR of -2.6% during review period.
Ceftriaxone sodium is a cephalosporin antibiotic.
There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.
Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.
For the production, China and India are the mainly manufactured base.
Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.
This report is a detailed and comprehensive analysis for global Ceftriaxone Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ceftriaxone Sodium market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Ceftriaxone Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Ceftriaxone Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Ceftriaxone Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ceftriaxone Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ceftriaxone Sodium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, Orchid Pharma, Medya Pharma, REYOUNG, LKPC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Ceftriaxone Sodium market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
ChP
USP
EP
麻豆原创 segment by Application
Single Injection
Compound Injection
Major players covered
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ceftriaxone Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ceftriaxone Sodium, with price, sales quantity, revenue, and global market share of Ceftriaxone Sodium from 2020 to 2025.
Chapter 3, the Ceftriaxone Sodium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ceftriaxone Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ceftriaxone Sodium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ceftriaxone Sodium.
Chapter 14 and 15, to describe Ceftriaxone Sodium sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Ceftriaxone Sodium Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 ChP
1.3.3 USP
1.3.4 EP
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Ceftriaxone Sodium Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Single Injection
1.4.3 Compound Injection
1.5 Global Ceftriaxone Sodium 麻豆原创 Size & Forecast
1.5.1 Global Ceftriaxone Sodium Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Ceftriaxone Sodium Sales Quantity (2020-2031)
1.5.3 Global Ceftriaxone Sodium Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Shandong Ruiying
2.1.1 Shandong Ruiying Details
2.1.2 Shandong Ruiying Major Business
2.1.3 Shandong Ruiying Ceftriaxone Sodium Product and Services
2.1.4 Shandong Ruiying Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Shandong Ruiying Recent Developments/Updates
2.2 Qilu Antibiotics
2.2.1 Qilu Antibiotics Details
2.2.2 Qilu Antibiotics Major Business
2.2.3 Qilu Antibiotics Ceftriaxone Sodium Product and Services
2.2.4 Qilu Antibiotics Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Qilu Antibiotics Recent Developments/Updates
2.3 Nectar Lifesciences
2.3.1 Nectar Lifesciences Details
2.3.2 Nectar Lifesciences Major Business
2.3.3 Nectar Lifesciences Ceftriaxone Sodium Product and Services
2.3.4 Nectar Lifesciences Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Nectar Lifesciences Recent Developments/Updates
2.4 Kelun
2.4.1 Kelun Details
2.4.2 Kelun Major Business
2.4.3 Kelun Ceftriaxone Sodium Product and Services
2.4.4 Kelun Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Kelun Recent Developments/Updates
2.5 United Laboratories
2.5.1 United Laboratories Details
2.5.2 United Laboratories Major Business
2.5.3 United Laboratories Ceftriaxone Sodium Product and Services
2.5.4 United Laboratories Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 United Laboratories Recent Developments/Updates
2.6 Aurobindo Pharma
2.6.1 Aurobindo Pharma Details
2.6.2 Aurobindo Pharma Major Business
2.6.3 Aurobindo Pharma Ceftriaxone Sodium Product and Services
2.6.4 Aurobindo Pharma Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Aurobindo Pharma Recent Developments/Updates
2.7 Orchid Pharma
2.7.1 Orchid Pharma Details
2.7.2 Orchid Pharma Major Business
2.7.3 Orchid Pharma Ceftriaxone Sodium Product and Services
2.7.4 Orchid Pharma Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Orchid Pharma Recent Developments/Updates
2.8 Medya Pharma
2.8.1 Medya Pharma Details
2.8.2 Medya Pharma Major Business
2.8.3 Medya Pharma Ceftriaxone Sodium Product and Services
2.8.4 Medya Pharma Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Medya Pharma Recent Developments/Updates
2.9 REYOUNG
2.9.1 REYOUNG Details
2.9.2 REYOUNG Major Business
2.9.3 REYOUNG Ceftriaxone Sodium Product and Services
2.9.4 REYOUNG Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 REYOUNG Recent Developments/Updates
2.10 LKPC
2.10.1 LKPC Details
2.10.2 LKPC Major Business
2.10.3 LKPC Ceftriaxone Sodium Product and Services
2.10.4 LKPC Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 LKPC Recent Developments/Updates
2.11 ACS Dobfar
2.11.1 ACS Dobfar Details
2.11.2 ACS Dobfar Major Business
2.11.3 ACS Dobfar Ceftriaxone Sodium Product and Services
2.11.4 ACS Dobfar Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 ACS Dobfar Recent Developments/Updates
2.12 NCPC
2.12.1 NCPC Details
2.12.2 NCPC Major Business
2.12.3 NCPC Ceftriaxone Sodium Product and Services
2.12.4 NCPC Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 NCPC Recent Developments/Updates
2.13 Dawnrays
2.13.1 Dawnrays Details
2.13.2 Dawnrays Major Business
2.13.3 Dawnrays Ceftriaxone Sodium Product and Services
2.13.4 Dawnrays Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Dawnrays Recent Developments/Updates
2.14 Kopran
2.14.1 Kopran Details
2.14.2 Kopran Major Business
2.14.3 Kopran Ceftriaxone Sodium Product and Services
2.14.4 Kopran Ceftriaxone Sodium Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Kopran Recent Developments/Updates
3 Competitive Environment: Ceftriaxone Sodium by Manufacturer
3.1 Global Ceftriaxone Sodium Sales Quantity by Manufacturer (2020-2025)
3.2 Global Ceftriaxone Sodium Revenue by Manufacturer (2020-2025)
3.3 Global Ceftriaxone Sodium Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Ceftriaxone Sodium by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Ceftriaxone Sodium Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Ceftriaxone Sodium Manufacturer 麻豆原创 Share in 2024
3.5 Ceftriaxone Sodium 麻豆原创: Overall Company Footprint Analysis
3.5.1 Ceftriaxone Sodium 麻豆原创: Region Footprint
3.5.2 Ceftriaxone Sodium 麻豆原创: Company Product Type Footprint
3.5.3 Ceftriaxone Sodium 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Ceftriaxone Sodium 麻豆原创 Size by Region
4.1.1 Global Ceftriaxone Sodium Sales Quantity by Region (2020-2031)
4.1.2 Global Ceftriaxone Sodium Consumption Value by Region (2020-2031)
4.1.3 Global Ceftriaxone Sodium Average Price by Region (2020-2031)
4.2 North America Ceftriaxone Sodium Consumption Value (2020-2031)
4.3 Europe Ceftriaxone Sodium Consumption Value (2020-2031)
4.4 Asia-Pacific Ceftriaxone Sodium Consumption Value (2020-2031)
4.5 South America Ceftriaxone Sodium Consumption Value (2020-2031)
4.6 Middle East & Africa Ceftriaxone Sodium Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Ceftriaxone Sodium Sales Quantity by Type (2020-2031)
5.2 Global Ceftriaxone Sodium Consumption Value by Type (2020-2031)
5.3 Global Ceftriaxone Sodium Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Ceftriaxone Sodium Sales Quantity by Application (2020-2031)
6.2 Global Ceftriaxone Sodium Consumption Value by Application (2020-2031)
6.3 Global Ceftriaxone Sodium Average Price by Application (2020-2031)
7 North America
7.1 North America Ceftriaxone Sodium Sales Quantity by Type (2020-2031)
7.2 North America Ceftriaxone Sodium Sales Quantity by Application (2020-2031)
7.3 North America Ceftriaxone Sodium 麻豆原创 Size by Country
7.3.1 North America Ceftriaxone Sodium Sales Quantity by Country (2020-2031)
7.3.2 North America Ceftriaxone Sodium Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Ceftriaxone Sodium Sales Quantity by Type (2020-2031)
8.2 Europe Ceftriaxone Sodium Sales Quantity by Application (2020-2031)
8.3 Europe Ceftriaxone Sodium 麻豆原创 Size by Country
8.3.1 Europe Ceftriaxone Sodium Sales Quantity by Country (2020-2031)
8.3.2 Europe Ceftriaxone Sodium Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Ceftriaxone Sodium Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Ceftriaxone Sodium Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Ceftriaxone Sodium 麻豆原创 Size by Region
9.3.1 Asia-Pacific Ceftriaxone Sodium Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Ceftriaxone Sodium Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Ceftriaxone Sodium Sales Quantity by Type (2020-2031)
10.2 South America Ceftriaxone Sodium Sales Quantity by Application (2020-2031)
10.3 South America Ceftriaxone Sodium 麻豆原创 Size by Country
10.3.1 South America Ceftriaxone Sodium Sales Quantity by Country (2020-2031)
10.3.2 South America Ceftriaxone Sodium Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Ceftriaxone Sodium Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Ceftriaxone Sodium Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Ceftriaxone Sodium 麻豆原创 Size by Country
11.3.1 Middle East & Africa Ceftriaxone Sodium Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Ceftriaxone Sodium Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Ceftriaxone Sodium 麻豆原创 Drivers
12.2 Ceftriaxone Sodium 麻豆原创 Restraints
12.3 Ceftriaxone Sodium Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Ceftriaxone Sodium and Key Manufacturers
13.2 Manufacturing Costs Percentage of Ceftriaxone Sodium
13.3 Ceftriaxone Sodium Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Ceftriaxone Sodium Typical Distributors
14.3 Ceftriaxone Sodium Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
Kelun
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
听
听
*If Applicable.
